Yiran Chen

机构：City University, Hangzhou City University, East China Normal University · ORCID：0000-0002-9507-4007

发表论文 81 篇 · 总被引 1078 次 · h-index 18

代表论文

• Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer (2024 · Molecular Therapy · 被引 34)
• A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma (2024 · Frontiers in Immunology · 被引 23)
• GPR132 regulates the function of NK cells through the Gαs/CSK/ZAP70/NF-κB signaling pathway as a potential immune checkpoint (2025 · Science Advances · 被引 19)
• Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer (2025 · Pharmacological Research · 被引 19)
• Targeting Deltex E3 Ubiquitin Ligase 2 Inhibits Tumor‐associated Neutrophils and Sensitizes Hepatocellular Carcinoma Cells to Immunotherapy (2024 · Advanced Science · 被引 11)
• Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions (2024 · BMC Cancer · 被引 10)